275 related articles for article (PubMed ID: 27063076)
1. The mechanosensitive APJ internalization via clathrin-mediated endocytosis: A new molecular mechanism of cardiac hypertrophy.
He L; Chen L; Li L
Med Hypotheses; 2016 May; 90():6-10. PubMed ID: 27063076
[TBL] [Abstract][Full Text] [Related]
2. APJ acts as a dual receptor in cardiac hypertrophy.
Scimia MC; Hurtado C; Ray S; Metzler S; Wei K; Wang J; Woods CE; Purcell NH; Catalucci D; Akasaka T; Bueno OF; Vlasuk GP; Kaliman P; Bodmer R; Smith LH; Ashley E; Mercola M; Brown JH; Ruiz-Lozano P
Nature; 2012 Aug; 488(7411):394-8. PubMed ID: 22810587
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced internalization and desensitization of the apelin receptor.
Pope GR; Tilve S; McArdle CA; Lolait SJ; O'Carroll AM
Mol Cell Endocrinol; 2016 Dec; 437():108-119. PubMed ID: 27492965
[TBL] [Abstract][Full Text] [Related]
4. Apelin/ELABELA-APJ system in cardiac hypertrophy: Regulatory mechanisms and therapeutic potential.
Pang B; Jiang YR; Xu JY; Shao DX; Hao LY
Eur J Pharmacol; 2023 Jun; 949():175727. PubMed ID: 37062502
[TBL] [Abstract][Full Text] [Related]
5. Apelin/APJ system: A bifunctional target for cardiac hypertrophy.
Lu L; Wu D; Li L; Chen L
Int J Cardiol; 2017 Mar; 230():164-170. PubMed ID: 27979574
[TBL] [Abstract][Full Text] [Related]
6. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.
Chen X; Bai B; Tian Y; Du H; Chen J
J Biol Chem; 2014 Nov; 289(45):31173-87. PubMed ID: 25271156
[TBL] [Abstract][Full Text] [Related]
7. ELABELA: a novel hormone in cardiac development acting as a new endogenous ligand for the APJ receptor.
Xie F; Lv D; Chen L
Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):620-2. PubMed ID: 24829400
[No Abstract] [Full Text] [Related]
8. Cell-cell fusion and internalization of the CNS-based, HIV-1 co-receptor, APJ.
Zhou N; Fan X; Mukhtar M; Fang J; Patel CA; DuBois GC; Pomerantz RJ
Virology; 2003 Mar; 307(1):22-36. PubMed ID: 12667811
[TBL] [Abstract][Full Text] [Related]
9. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
Huang Z; He L; Chen Z; Chen L
J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
[TBL] [Abstract][Full Text] [Related]
10. Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.
Deng C; Chen H; Yang N; Feng Y; Hsueh AJ
J Biol Chem; 2015 Jul; 290(30):18261-8. PubMed ID: 25995451
[TBL] [Abstract][Full Text] [Related]
11. [Functional dissociation between apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure].
Iturrioz X; El Messari S; De Mota N; Fassot C; Alvear-Perez R; Maigret B; Llorens-Cortes C
Arch Mal Coeur Vaiss; 2007 Aug; 100(8):704-8. PubMed ID: 17928781
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1-Autophagy Pathway Mediated Cardiomyocyte Hypertrophy Induced by Apelin-13.
Wu D; Xie F; Xiao L; Feng F; Huang S; He L; Liu M; Zhou Q; Li L; Chen L
DNA Cell Biol; 2017 Aug; 36(8):611-618. PubMed ID: 28537760
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles.
Jiang Y; Yan M; Wang C; Wang Q; Chen X; Zhang R; Wan L; Ji B; Dong B; Wang H; Chen J
Front Pharmacol; 2021; 12():630548. PubMed ID: 33746758
[TBL] [Abstract][Full Text] [Related]
14. Elabela-apelin receptor signaling pathway is functional in mammalian systems.
Wang Z; Yu D; Wang M; Wang Q; Kouznetsova J; Yang R; Qian K; Wu W; Shuldiner A; Sztalryd C; Zou M; Zheng W; Gong DW
Sci Rep; 2015 Feb; 5():8170. PubMed ID: 25639753
[TBL] [Abstract][Full Text] [Related]
15. Apelin-13/APJ induces cardiomyocyte hypertrophy by activating the Pannexin-1/P2X7 axis and FAM134B-dependent reticulophagy.
Yang Y; Zhang K; Huang S; Chen W; Mao H; Ouyang X; Chen L; Li L
J Cell Physiol; 2022 Apr; 237(4):2230-2248. PubMed ID: 35128666
[TBL] [Abstract][Full Text] [Related]
16. Apelin/APJ signaling promotes hypoxia-induced proliferation of endothelial progenitor cells via phosphoinositide-3 kinase/Akt signaling.
Zhang J; Liu Q; Hu X; Fang Z; Huang F; Tang L; Zhou S
Mol Med Rep; 2015 Sep; 12(3):3829-3834. PubMed ID: 26018184
[TBL] [Abstract][Full Text] [Related]
17. [The functional role of endogenous APJ agonists; Apelin and Elabela/Toddler in cardiovascular diseases].
Sato T; Kuba K
Nihon Yakurigaku Zasshi; 2019; 153(4):172-178. PubMed ID: 30971657
[TBL] [Abstract][Full Text] [Related]
18. Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure.
El Messari S; Iturrioz X; Fassot C; De Mota N; Roesch D; Llorens-Cortes C
J Neurochem; 2004 Sep; 90(6):1290-301. PubMed ID: 15341513
[TBL] [Abstract][Full Text] [Related]
19. Endogenous regulation of cardiovascular function by apelin-APJ.
Charo DN; Ho M; Fajardo G; Kawana M; Kundu RK; Sheikh AY; Finsterbach TP; Leeper NJ; Ernst KV; Chen MM; Ho YD; Chun HJ; Bernstein D; Ashley EA; Quertermous T
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1904-13. PubMed ID: 19767528
[TBL] [Abstract][Full Text] [Related]
20. Non-activated APJ suppresses the angiotensin II type 1 receptor, whereas apelin-activated APJ acts conversely.
Sun X; Iida S; Yoshikawa A; Senbonmatsu R; Imanaka K; Maruyama K; Nishimura S; Inagami T; Senbonmatsu T
Hypertens Res; 2011 Jun; 34(6):701-6. PubMed ID: 21412239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
